Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases - WAYNE, Pa., ...

Kuick Research Report Highlights Ongoing Developments In Molecular Switches Application Therapeutic Targets & Drug Delivery ...

Aclaris Therapeutics (ACRS) announced the availability of a new publication describing properties of Aclaris Therapeutics’ ATI-2138, a novel ...

forming the glycocalix of the cell. A positive carbohydrate-carbohydrate or carbohydrate-protein interaction will lead subsequently to a signal transduction into the cell, initiating various ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy. The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

A new study reveals that modifying the CUL5 gene enhances CAR-T cell therapy for leukemia and lymphoma. This improves cell ...

Researchers have discovered a new mechanism that is used by a male sex hormone essential for muscle and bone function. The ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced significant findings about ATI-2138, a novel investigational drug ...